Pharmaids Pharmaceuticals Ltd Share Price

Pharmaceuticals

BSE: 524572 Small Cap ISIN: INE117D01018

As on 08 July 2026 at 23:11 IST

₹29.98

+ 1.46

(5.12%)

Sell Buy

Over 1 Month

-8.53%

Over 6 Months

-43.02%

Over 1 Year

-51.42%

Over 3 Years

-4.93%

Pharmaids Pharmaceuticals Ltd Summary

Close ₹28.52

Open ₹28.26

High ₹28.97

Low ₹27.60

Volume 4,865

Net Turnover (in Cr) ₹0.013

52Wk High ₹70

52Wk Low ₹25.60

52Wk High / Low

25.60

Pharmaids Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹100.58

EPS (TTM) -

Book Value (BV) 15.13

Div. Yield -

P/E (TTM) -9.64

Price/Book Value 1.88

Delivery % 81.52 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 3.80

EV to Sales 120.27

PEG Ratio -

ROA -7.03

ROE -

Debt-Equity 0.39

Net Profit Margin -311.11

Operating Profit Margin -266.67

Pharmaids Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	19.55	15.99	-	3.95
Total Expenses	36.73	30.79	9.91	3.81
Profit Before Tax	-17.28	-15.62	-9.91	0.14
Profit After Tax	-13.51	-11.84	-7.56	0.15
Operating Profit After Depreciation	-15.09	-13.23	-9.90	0.14

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Fixed Assets	76.61	63.42	0.11	0.03
Total Non Current Assets	97.55	77.81	7.07	8.44
Total Current Assets	22.31	13.53	17.51	2.67
Total Assets	119.85	91.34	24.59	11.11
Total Shareholder's Fund	59.32	72.05	22.46	8.67

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash From Operating Activities	-13.99	-10.62	-4.02	-0.26
Net Cash Used In Investing Activities	-12.02	-74.99	-4.94	0.47
Net Cash Used In Financing Activities	23.36	77.66	21.31	-

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	3.36	0.82	-	3.95	8.58
Total Expenses	11.95	6.91	9.91	3.81	8.49
Profit Before Tax	-8.59	-6.09	-9.91	0.14	0.09
Profit After Tax	-7.28	-4.95	-7.56	0.15	0.09
Operating Profit After Depreciation	-6.44	-5.75	-9.91	0.14	0.09

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	24.18	16.55	0.11	0.03	0.04
Total Non Current Assets	106.01	80.24	6.27	8.44	8.26
Total Current Assets	12.68	4.76	18.28	2.67	0.86
Total Assets	118.69	85	24.55	11.11	9.12
Total Shareholder's Fund	63.79	71.06	22.43	8.67	8.53

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-7.72	-3.44	-4.02	-0.26	0.41
Net Cash Used In Investing Activities	-18.90	-72.51	-4.95	0.47	-0.23
Net Cash Used In Financing Activities	24.64	65.66	21.31	-	-

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	7.18	5.43	8.61	6.66	4.77
Total Expenses	7.52	7.93	13.92	12.03	8.68
Profit Before Tax	-1.46	-4.02	-3.69	-7.14	-5.41
Profit After Tax	-1.08	-2.65	-2.56	-5.28	-4.80
Operating Profit after Depreciation	-0.24	-2.42	-5.24	-5.33	-3.84

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	2.69	0.83	5.97	1.12	0.13
Total Expenses	3.77	4.51	10.54	5.99	2.82
Profit Before Tax	-1.69	-4.24	-2.33	-5.68	-3.78
Profit After Tax	-1.31	-3.11	-1.65	-4.36	-3.06
Operating Profit after Depreciation	-1.02	-3.62	-4.38	-4.52	-1.68

Pharmaids Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 27.76

S2 26.99

S3 26.39

Pivot 28.36

R1 29.13

R2 29.73

R3 30.50

Moving Average

20 SMA 28.52

50 SMA 29.59

100 SMA 33.68

200 SMA 42.86

Pharmaids Pharmaceuticals Ltd Corporate Actions

No available data

AGM Date: 25 Sep 2021

Dear Sir / Madam Please find attached the Outcome of the Board Meeting held on 20th August 2021. Further we would like to inform you that the 32nd Annual General Meeting (AGM) of Pharmaids Pharmaceuticals Limited is scheduled to be held on 25th September 2021 at 12:00 P.M. through VC / OAVM. In compliance with provisions of Section 108 of the Companies Act 2013 and Rule 20 of the Companies (Management and Administration) Rules 2014 and Reg. 44 of SEBI (LODR) Regulation 2015 the Company is pleased to provide the Remote E-Voting facility to its Shareholders to exercise their Vote by E-mode and the business may be transacted through E-Voting Services and VC / OAVM Facility. Kindly take the same on record. For Pharmaids Pharmaceuticals Limited S Padmaja Kalyani Director 32nd AGM held on 25 September 2021 Through VC/OVAC. Dear Sir Please find the attached outcome of the 32nd Annual General Meeting which was held on 25th September 2021. Kindly take same on the record. Regards Pharmaids Pharmaceuticals Limited S Padmaja Kalyani Director (As Per BSE Announcement Dated on 9/25/2021 1:11:36 AM) Pharmaids Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Dear Sir, Further to our letter dated 20th August 2021, informing the date of Annual General Meeting (AGM) being held as under and the Cut-off date for e-Voting respectively, we now send herewith the Voting Results (Consolidated: Remote e-Voting and e-Voting during the AGM) on the Resolutions forming part of the Notice of the 32nd AGM of the Company held on Saturday, 25th September 2021 at 12.00 Noon through Video Conferencing, pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. For PHARMAIDS PHARMACEUTICALS LIMITED S Padmaja Kalyani Director (As per BSE Announcement Dated on 27/09/2021)

AGM Date: 20 Aug 2022

AGM 20/08/2022 Dear Sir/ Madam, Please find the attached Outcome of Board Meeting regarding approval of Un Audited Financial Statements for the Quarter ended 30.06.2022 along With Limited Review Report and Matters Regarding AGM. This is for your information and dissemination. Regards, For Pharmaids Pharmaceuticals Limited S. Venkat Rao Director (As Per BSE Announcement Dated on 22.07.2022) Proceedings of 33rd AGM (As Per BSE Announcement Dated on 20.08.2022) Dear Sir/Madam, This is to inform that 33rd Annual General Meeting ('AGM') of the Company was conducted on August 20, 2022 at 12:00 P.M. through Video Conferencing ('VC') and/or Other Audio Visual Means ('OVAM') in compliance with the Companies Act, SEBI (LODR) Regulations, Secretarial Standards and various circulars issued by MCA in connection with conducting AGM through VC or OVAM. In this regard, Please find enclosed the following: 1. Disclosure of Voting results in terms of Regulation 44(3) of SEBI (LODR) Regulations. 2. Scrutinizers' report by Mr. Kashinath Sahu, Practicing Company Secretary. All the resolutions mentioned in the notice of AGM were passed unanimously. This is for your information and for dissemination to general public. For Pharmaids Pharmaceuticals Limited Annie Jodhani Company Secretary & Compliance Officer (As Per BSE Announcement Dated on 22.08.2022)

AGM Date: 22 Sep 2023

Outcome of the Board Meeting held on 29th August , 2023 for approval of Annual Financial Statements for the financial year 2022-23 and AGM related matters. With reference to Regulation 47 and other applicable regulations, if any, of the SEBI (LODR), Regulations, 2015, please find enclosed the copy of Newpaper Advertisement published on 01, September 2023, intimating the Notice of 34th Annual Genral Meeting of the Company. (As Per BSE Announcement Dated on 01/09/2023) Outcome of the 34th Annual general meeting of the Company held on 22nd September, 2023 at 12:30 p.m. through VC/OAVM. (As per BSE Announcement Dated on 22/09/2023) Voting results along with scrutinizer report of the 34th Annual General Meeting held on Friday, 22 September 2023. (As per BSE Announcement Dated on 25/09/2023)

AGM Date: 25 Sep 2024

The Board decided to convene the 35th Annual General Meeting of the Company on Wednesday, September 25, 2024, at 11:30 A.M. through Video Conferencing (VC) / Other Audio Visual Means ('OAVM'), in compliance with the SEBI Circulars and MCA Circulars, allowing the Companies to hold the Annual General Meeting through Video Conferencing / Other AudioVisual Means. Outcome of the 35th Annual General Meeting of the Company held on 25, September 2024, i.e., Today, at 11:30 a.m. through VC/OAVM. (As Per BSE Announcement Dated on 25.09.2024)

AGM Date: 23 Sep 2025

AGM 23/09/2025 The 36th Annual General Meeting is scheduled to be held on Tuesday, September 23, 2025 at 11.30 AM through VC/OAVM. Plesae find the Annual Report for the FY 2024-25 containing notice of the AGM. (As per BSE Announcement Dated on 29/08/2025) Outcome of the 36th Annual General Meeting of the Company held on September 23, 2025, i.e., Today at 11:30 a.m. through VC/OAVM. (As Per BSE Announcement Dated on 23.09.2025) Voting Results along with the Scrutiniser''s Report of the 36th AGM of the Company held on 23rd September 2025 through VC/OAVM. Please find attached intimation regarding appointment of Secretarial Auditors. (As Per BSE Announcement Dated on 24.09.2025)

EGM Date: 31 Dec 2022

Dear Sir/Madam, Outcome of the Board Meeting held on 06.12.2022 for Conversion of Share Warrants and allotment of Equity shares pursuant to the Conversion, Convening of the EGM and other related matters. EGM to be held on December 31, 2022 At 12.00 Noon - Uploading of EGM Notice, as dispatched to the shareholders today. (As Per BSE Announcement Dated on 07/12/2022) Dear Sir/Madam Please find the enclosed outcome of the 1st Extraordinary General Meeting for the Financial Year 2022-23 held today i.e. 31st December, 2022 for dissemination. Regards For Pharmaids Pharmaceuticals Limited Kaushik Kumar Company Secretary (As Per BSE Announcement Dated on 31.12.2022) Dear Sir/ Madam, Please find Voting Result along with Scrutinizer Report on the matter placed for approval at the 1st Extraordinary General Meeting for the Financial Year 2022-23 of the Company held on 31st December, 2022. Thanks & Regards For Pharmaids Pharmaceuticals Limited Kaushik Kumar Company Secretary (As Per BSE Announcement Dated on 03/01/2023)

EGM Date: 31 Jan 2024

Outcome of the Board meeting held on saturday, 06 January 2024. The Board decided to convene the 01st Extra Ordinary General Meeting of the Company on Wednesday, January 31, 2024 at 11:30 A.M. through Video Conferencing (VC) / Other AudioVisual Means ('OAVM'), in compliance with the SEBI Circulars and MCA Circulars issued from time to time, allowing the Companies to hold the General Meeting through Video Conferencing / Other Audio-Visual Means. This is to inform that the Company''s Extraordinary General Meeting is scheduled to be held on Wednesday, 31 January, 2024 at 11:30 A.M. through Video Conferencing/Other Audio Visual Means ('VC/OAVM'). we are attaching herewith Notice of the EGM and Explanatory Statement thereto. (As Per BSE Announcement Dated on 08/01/2024) Newspaper Advertisement of Notice of 01st Extraordinary General Meeting for the Financial year 2023-24 to be held on Wednesday, 31st January 2024, along with E-voting facility and cut-off date. (As per BSE Announcement Dated on 09/01/2024) EGM 31/01/2024 (As Per BSE Bulletin Dated on 18.01.2024) Proceedings of the Extraordinary general meeting held on 31st January 2024 at 11:30 a.m. through VC/OAVM (As Per BSE Announcement Dated on 31/01/2024) Voting results along with scrutiniser report of the 01st Extraordinary General Meeting for the Financial Year 2023-24 held on Wednesday, 31st January 2024 at 11:30 A.M. thorugh VC/OAVM. (As Per BSE Announcement Dated on 02/02/2024) This is to inform you that the shareholders of the company in their Extraordinary General Meeting held on Wednesday, 31st January 2024, approved the appointment of Dr. Shankarappa Nagaraja Vinaya Babu (DIN: 01373832) as Director and Chairman (Non executive & Non Independent Category) of the company. Intimation of Alteration in Object Clause and Capital Clause of the Memorandum of Association of the Company. (As Per BSE Announcement Dated on 09/02/2024)

Pharmaids Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Pharmaids Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Pharmaids Pharmaceuticals Ltd News

Pharmaids Pharmaceuticals to conduct board meeting

On 29 May 2026

23 May 2026, 05:55 pm

Pharmaids Pharmaceuticals announces divestment of step-down subsidiary

28 Mar 2026, 10:53 am

Pharmaids Pharmaceuticals schedules board meeting

On 12 February 2026

09 Feb 2026, 04:52 pm

Pharmaids Pharmaceuticals schedules board meeting

On 11 November 2025

07 Nov 2025, 12:02 pm

Pharmaids Pharmaceuticals schedules AGM

On 23 September 2025

02 Sep 2025, 12:30 pm

Pharmaids Pharmaceuticals Ltd Stock Analysis

Annual revenue for Pharmaids Pharmaceuticals Ltd increased by 308.34% to ₹3.36 crore in FY 2025 from ₹0.82 crore in FY 2024.
Annual Net Profit for Pharmaids Pharmaceuticals Ltd increased by 47.06% to ₹-7.28 crore in FY 2025 from ₹-4.95 crore in FY 2024.
Promoter Shareholding in Pharmaids Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 32.99% in December 2025 to 32.99% in March 2026.
Pharmaids Pharmaceuticals Ltd delivered a 1-year return of -51.42% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Pharmaids Pharmaceuticals Ltd share price moved up by 5.12% from its previous close of INR ₹28.52. The latest Pharmaids Pharmaceuticals Ltd share price is INR ₹29.98.
Pharmaids Pharmaceuticals Ltd share price today has been at a low of 27.51 and a high of 30.90. Over the past 52 weeks, the Pharmaids Pharmaceuticals Ltd share price has seen a low of 25.60 and a high of 70.